Monte Rosa Therapeutics
GLUE
#7806
Rank
A$0.40 B
Marketcap
$6.53
Share price
1.54%
Change (1 day)
-39.12%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2023 (TTM): -$3.86

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.25. In 2022 the company made an earnings per share (EPS) of -$3.79 an increase over its 2021 EPS that were of -$8.03.

EPS history for Monte Rosa Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.861.82%
2022-$3.79-52.81%
2021-$8.03193.97%
2020-$2.73